RE: Share price15 Sep 2022 18:47
I think you've nailed it 44RJ. Personally, I can see the reasoning for the strategy. At the time, Scirocco had no income and the BOD was looking at a large expense to develop Ruvuma. So a strategy of monetising assets and reducing the liabilities made a lot of sense. If Horse Hill and He1 sales netted a few million, and these were swapped for 3 or 4 AD plants, that all generated £1.3m revenue and £600k gross profit, we'd be sitting here of revenue of £4-5m, net profit of say £1m per annum, and a mcap of £10m on that alone. With Ruvuma still in hand, the choice would remain - fund or sell. Sell Ruvuma for a few million, get another 2 or 3 AD plants, turnover now £7-8m, profit £1.5m. Plus maybe retain staged payments of Ruvuma income. Happy days.
But the problem has been the expenditure along the way, not delivering the portfolio of AD assets, and generally silence. All of that would be forgiven if Ruvuma was sold for $20m cash. But it's not. So shareholders are now p@$$ed off.